Aristotle Capital Management’s Pfizer PFE Stock Holding History

Aristotle Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.11M	Hold	46,072	–	–	﹤0.01%	156
2026 Q1	$1.29M	Hold	46,072	–	–	﹤0.01%	157
2025 Q4	$1.15M	Hold	46,072	–	–	﹤0.01%	161
2025 Q3	$1.17M	Hold	46,072	–	–	﹤0.01%	160
2025 Q2	$1.12M	Hold	46,072	–	–	﹤0.01%	159
2025 Q1	$1.17M	Hold	46,072	–	–	﹤0.01%	152
2024 Q4	$1.22M	Hold	46,072	–	–	﹤0.01%	156
2024 Q3	$1.33M	Hold	46,072	–	–	﹤0.01%	154
2024 Q2	$1.29M	Hold	46,072	–	–	﹤0.01%	151
2024 Q1	$1.28M	Hold	46,072	–	–	﹤0.01%	152
2023 Q4	$1.33M	Sell	46,072 -2,309	-5%	-$69.8K	﹤0.01%	147
2023 Q3	$1.6M	Hold	48,381	–	–	﹤0.01%	143
2023 Q2	$1.77M	Sell	48,381 -17,733	-27%	-$690K	﹤0.01%	142
2023 Q1	$2.7M	Sell	66,114 -1,000	-1%	-$43.2K	0.01%	138
2022 Q4	$3.44M	Hold	67,114	–	–	0.01%	133
2022 Q3	$2.94M	Hold	67,114	–	–	0.01%	136
2022 Q2	$3.52M	Hold	67,114	–	–	0.01%	134
2022 Q1	$3.47M	Hold	67,114	–	–	0.01%	138
2021 Q4	$3.96M	Sell	67,114 -1,086	-2%	-$53.8K	0.01%	137
2021 Q3	$2.93M	Sell	68,200 -979	-1%	-$43.4K	0.01%	137
2021 Q2	$2.71M	Hold	69,179	–	–	0.01%	134
2021 Q1	$2.51M	Hold	69,179	–	–	0.01%	134
2020 Q4	$2.55M	Sell	69,179 -6,227	-8%	-$228K	0.01%	137
2020 Q3	$2.63M	Sell	75,406 -255	-0.3%	-$8.94K	0.01%	134
2020 Q2	$2.35M	Buy	75,661 +250	+0.3%	+$8.49K	0.01%	131
2020 Q1	$2.33M	Buy	75,411 +5	+0%	+$170	0.01%	129
2019 Q4	$2.8M	Hold	75,406	–	–	0.01%	128
2019 Q3	$2.57M	Sell	75,406 -7,833	-9%	-$285K	0.01%	132
2019 Q2	$3.42M	Sell	83,239 -1,897	-2%	-$75.3K	0.02%	128
2019 Q1	$3.43M	Sell	85,136 -158	-0.2%	-$6.33K	0.02%	126
2018 Q4	$3.53M	Hold	85,294	–	–	0.02%	122
2018 Q3	$3.57M	Hold	85,294	–	–	0.02%	122
2018 Q2	$2.94M	Hold	85,294	–	–	0.02%	125
2018 Q1	$2.87M	Hold	85,294	–	–	0.02%	119
2017 Q4	$2.93M	Hold	85,294	–	–	0.02%	121
2017 Q3	$2.89M	Buy	85,294 +2,607	+3%	+$83.8K	0.02%	92
2017 Q2	$2.63M	Sell	82,687 -527	-0.6%	-$16.6K	0.02%	66
2017 Q1	$2.7M	Hold	83,214	–	–	0.02%	67
2016 Q4	$2.56M	Hold	83,214	–	–	0.02%	68
2016 Q3	$2.67M	Sell	83,214 -9,486	-10%	-$317K	0.03%	66
2016 Q2	$3.1M	Sell	92,700 -6,324	-6%	-$202K	0.03%	66
2016 Q1	$2.79M	Sell	99,024 -22,832	-19%	-$652K	0.03%	67
2015 Q4	$3.73M	Sell	121,856 -4,954	-4%	-$156K	0.05%	65
2015 Q3	$3.78M	Sell	126,810 -18,708	-13%	-$600K	0.05%	67
2015 Q2	$4.63M	Sell	145,518 -6,975	-5%	-$227K	0.05%	65
2015 Q1	$5.03M	Sell	152,493 -930	-0.6%	-$29.6K	0.06%	65
2014 Q4	$4.53M	Sell	153,423 -466	-0.3%	-$13.4K	0.06%	68
2014 Q3	$4.32M	Sell	153,889 -680	-0.4%	-$19.1K	0.06%	67
2014 Q2	$4.35M	Buy	154,569 +1,304	+0.9%	+$37.2K	0.06%	98
2014 Q1	$4.67M	Hold	153,265	–	–	0.07%	68
2013 Q4	$4.45M	Sell	153,265 -475	-0.3%	-$13.8K	0.07%	69
2013 Q3	$4.19M	Sell	153,740 -2,733	-2%	-$74.4K	0.08%	70
2013 Q2	$4.16M	Buy	+156,473	New	+$4.32M	0.11%	57

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Aristotle Capital Management's PFE Position: Q2 2026 in Review

Aristotle Capital Management held its Pfizer (PFE) position steady in Q2 2026 at 46,072 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #156.

Aristotle Capital Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.03M in Q1 2015. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Aristotle Capital Management held 46,072 shares of Pfizer worth $1.11M as of Q2 2026.
Aristotle Capital Management left its Pfizer share count unchanged in Q2 2026.
Pfizer made up ﹤0.01% of Aristotle Capital Management's portfolio in Q2 2026, its #156 holding.
Aristotle Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Aristotle Capital Management's Pfizer position peaked at $5.03M in Q1 2015.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Aristotle Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.